Your browser doesn't support javascript.
loading
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka, Katsuyoshi; Watanabe, Mamoru; Ohmori, Toshihide; Nakajima, Koichi; Ishida, Tetsuya; Ishiguro, Yoh; Kanke, Kazunari; Kobayashi, Kiyonori; Hirai, Fumihito; Watanabe, Kenji; Mizusawa, Hidehiro; Kishida, Shuji; Miura, Yoshiharu; Ohta, Akira; Kajioka, Toshifumi; Hibi, Toshifumi.
Afiliación
  • Matsuoka K; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Toho University Sakura Medical Center, Sakura, Japan.
  • Watanabe M; Tokyo Medical and Dental University, Advanced Research Institute and Department of Gastroenterology and Hepatology, Tokyo, Japan. Electronic address: mamoru.gast@tmd.ac.jp.
  • Ohmori T; Department of Gastroenterology, Ohmori Toshihide Gastro-intestinal Clinic, Ageo, Japan.
  • Nakajima K; Department of Gastrointestinal Division, Matsushima Clinic, Yokohama, Japan.
  • Ishida T; Department of IBD and Gastroenterology, Ishida Clinic of IBD and Gastroenterology, Oita, Japan.
  • Ishiguro Y; Department of Gastroenterology and Hematology, National Hospital Organization Hirosaki National Hospital, Hirosaki, Japan.
  • Kanke K; Gastrointestinal Division, Kanke Gastrointestinal Clinic, Utsunomiya, Japan.
  • Kobayashi K; Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
  • Hirai F; Department of Gastroenterology and Medicine, Fukuoka University Hospital, Fukuoka, Japan.
  • Watanabe K; Division of Internal Medicine, Center for Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya, Japan.
  • Mizusawa H; Department of Neurology, National Center of Neurology and Psychiatry Hospital, Tokyo, Japan.
  • Kishida S; Cranial Nerve Internal Medicine Department, Narita Tomisato Tokushukai Hospital, Tomisato, Japan.
  • Miura Y; Department of Neurology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Ohta A; Clinical Development Department, EA Pharma, Tokyo, Japan.
  • Kajioka T; Clinical Development Department, EA Pharma, Tokyo, Japan.
  • Hibi T; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Lancet Gastroenterol Hepatol ; 7(7): 648-657, 2022 07.
Article en En | MEDLINE | ID: mdl-35366419
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Nasofaringitis Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Nasofaringitis Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos